Comparative study between enhanced and conventional recovery on postoperative outcomes in women candidates for laparoscopic surgery.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191123045476N1

Enrollment

160

Registered

2020-05-21

Start date

2019-10-23

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic gynecological surgery. Laparoscopic surgical procedure converted to open procedure

Interventions

Intervention 1: Intervention group will be 80 patients who were candidates laparoscopic for gynecological surgery. Perioperatively, this group will be managed according to Enhanced Recovery After Surg

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Not being anemia Not being infected Do not suffer from underlying disease (heart, lung, gastrointestinal, thyroid, nervous, mental, etc.). BMI<25.5

Exclusion criteria

Exclusion criteria: Conversion from laparoscopic surgery to laparotomy The unwillingness of women to continue the study. More interventions (blood transfusions,.....) Occurrence of unpredictable complications during surgery

Design outcomes

Primary

Measure	Time frame
Pain score. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Need for analgesia. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Fever. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Nausea and vomiting. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Diarrhea. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Postoperative infection,. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Length of hospital stay. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Hemoglobin changes. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Bleeding volume. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Resumption of bowel activity. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.	—

Measure

Time frame

Pain score. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Need for analgesia. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Fever. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Nausea and vomiting. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Diarrhea. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Postoperative infection,. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Length of hospital stay. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Hemoglobin changes. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Bleeding volume. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.;Resumption of bowel activity. Timepoint: After surgery. Method of measurement: Questionnaire and medical records.

—

Secondary

Measure	Time frame
Postoperative infection. Timepoint: 2 weeks after surgery. Method of measurement: Questionnaire.;Return to normal activity. Timepoint: 2 weeks after surgery. Method of measurement: Questionnaire.;Return to work. Timepoint: 2 weeks after surgery. Method of measurement: Questionnaire.;Hospital readmission. Timepoint: 2 weeks after surgery. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIran University of Medical Sciences

Iran University of Medical Sciences

s.rokhgireh@gmail.com+98 21 6650 9283

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026